Cargando…
Increase in the circulating level of hepatocyte growth factor in gastric cancer patients.
We measured serum concentrations of hapatocyte growth factor (HGF) in patients with gastric cancer and compared these with the histological findings and conventional tumour markers, including CEA, CA19-9 and CA125, for evaluation of the significance of serum HGF levels as a tumour marker. The HGF le...
Autores principales: | Taniguchi, T., Kitamura, M., Arai, K., Iwasaki, Y., Yamamoto, Y., Igari, A., Toi, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063328/ https://www.ncbi.nlm.nih.gov/pubmed/9043023 |
Ejemplares similares
-
Hepatocyte growth factor predicts failure of Fontan circulation
por: Kojima, Takuro, et al.
Publicado: (2020) -
Function of hepatocyte growth factor in gastric cancer proliferation and invasion
por: Koh, Sung Ae, et al.
Publicado: (2020) -
The Aromatase Gene (CYP19A1) Variants and Circulating Hepatocyte Growth Factor in Postmenopausal Women
por: Lin, Jennifer H., et al.
Publicado: (2012) -
Circulating Hepatocyte Growth Factor Reflects Activation of Vascular Repair in Response to Stress
por: Chen, Yihong, et al.
Publicado: (2022) -
Monitoring gastric cancer progression with circulating tumour DNA
por: Hamakawa, T, et al.
Publicado: (2015)